Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition

AmgenThe Amgen Foundation and Ashoka's Changemakers today announced three winners for the Patients | Choices | Empowerment competition. Each winner will receive a $10,000 cash prize and was selected by the public for their innovative solutions that empower and elevate patients' voices to improve health outcomes.

Out of 10 finalists, the entries receiving the most votes in the Changemakers.com competition are:

1. CureTogether - Crowdsourced Patient Experience
2. Educating Tuberculosis patients for excellent results
3. SMS Now! A Life Depends on It.

In addition, selected entries may be considered for additional grants totaling up to $1 million from the Amgen Foundation.

"The Patients | Choices | Empowerment winners demonstrate that it is possible to create innovative tools and resources that empower patients and offer collaborative solutions at every stage of healthcare," said Jean Lim, president of the Amgen Foundation. "This competition has helped to build a global community of innovators who are working to ensure that patients have an active role in their personal healthcare. We look forward to reviewing the entries to identify sustainable solutions that both the Amgen Foundation and other interested funders can support."

The winning entries are crowdsourcing quantitative data to help patients make more informed choices about their healthcare; removing the stigma around tuberculosis and encouraging and supporting treatment; and utilizing the internet and mobile technology to connect volunteer blood donors with patients. All of these innovations demonstrate global solutions.

"The Patients | Choices | Empowermentcompetition uncovered ideas that help patients makedecisions with confidence and clarity,in concertwithpeople who careand can help," said Diana Wells, president of Ashoka. "We are so pleased with the online community that joined the Changemakers platform, voted, and shared their feedback on these innovative solutions. We are also incredibly thankful to our expert judges and commentators who contributed to the creation of a rich, global dialogue on the important issues that ultimately resulted in the selection of three outstanding entries."

In addition to the $10,000 cash prizes, the three Patients | Choices | Empowermentcompetition winners will be featured on Changemakers.com as innovative ideas for empowering the patient and providing avenues for informed decisions.

About Ashoka's Changemakers
Ashoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker. www.Changemakers.com

About the Amgen Foundation
The Amgen Foundation seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

Most Popular Now

Primary endpoint met in COMET-TAIL Phase III trial…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase...

Merck and Ridgeback's molnupiravir, an oral COVID-…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Re...

Two billion doses of AstraZeneca’s COVID-19 vaccin…

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the l...

Johnson & Johnson COVID-19 vaccine named one o…

The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & ...

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, c...

Safety concerns raised for neuroblastoma candidate…

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Th...

Pfizer's novel COVID-19 oral antiviral treatment c…

Pfizer Inc. (NYSE: PFE) today announced its investigational novel COVID-19 oral antiviral candidate,PAXLOVID™, significantly reduced hospitalization and death, based on a...

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day...

'Dancing molecules' successfully repair severe spi…

Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal ...

Researchers reveal a strategy for next-generation …

A study led by the Garvan Institute of Medical Research has revealed a guide to developing COVID-19 vaccines that both prevent the coronavirus from infecting human cells ...

A target for potential cancer drugs may, in fact, …

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyro...

A commonly found parasite could treat certain type…

Scientists have discovered that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various ...